Nephrology News

SGLT2 Inhibitors Begin to Show Potential in Rheumatology Sodium-glucose cotransporter-2 inhibitors are not approved to treat gout, lupus, or lupus nephritis, but clinicians are uncovering signs of benefits in these conditions.
MDedge News, January 08, 2024
Medicare Bundled Payment Model Fails to Boost HF Outcomes Medicare's bundled payment model was not associated with changes in process-of-care measures or early outcomes after hospitalization for heart failure, a new study reported.
Medscape Medical News, January 08, 2024
Merck Seeks GLP-1 Drugs With Benefits Beyond Weight Loss - CEO Merck & Co is seeking GLP-1 treatments with benefits beyond weight loss, CEO Robert Davis said on Thursday at a conference.
Reuters Health Information, January 04, 2024
Digital Assistant Helps Ease an Overactive Bladder A digital tool may represent a more accessible and less expensive alternative to pelvic floor therapy.
Medscape Medical News, January 03, 2024
Weight-loss Drugs: Who, and What, Are They Good For? Powerful weight-loss medicines like Novo Nordisk's Wegovy leapt into public view in 2023, from social media to doctors' offices and cocktail parties, offering a new way to...
Reuters Health Information, January 02, 2024
Explainer-What Other Health Conditions Might Weight-loss Drugs Treat? Novo Nordisk's blockbuster diabetes drug Ozempic and weight-loss therapy Wegovy are being studied to see whether they can improve health in other ways.
Reuters Health Information, January 02, 2024
Amoxicillin Short Course Effective for Febrile UTIs Children treated with oral antibiotics for 5 days showed similar UTI recurrence rates at 30 days posttreatment to those who received the standard 10-day course.
Medscape Medical News, December 29, 2023
Hospital Adverse Events Rise Post Private Equity Acquisition However, in-hospital mortality rates were not significantly different at private equity hospitals compared with control hospitals.
Medscape Medical News, December 29, 2023
Sustained Weight Loss Linked to Lower Renal Risk in Diabetes Researchers report an independent inverse link between time spent within a target body weight range and composite kidney outcomes in individuals with overweight/obesity and type 2 diabetes.
Medscape Medical News, December 28, 2023
Alert Positive Topline Results for SEQUOIA-HCM Trial in OHCM Preliminary results of the pivotal phase 3 trial show benefit of the cardiac myosin inhibitor, aficamten, in obstructive hypertrophic cardiomyopathy.
Medscape Medical News, December 28, 2023
AHA Names Top CVD Advances for 2023 Advances in stroke, a novel antihypertensive, and new evidence that diabetes drugs may offer CVD benefits for those without diabetes are among the top developments in 2023, on the AHA's annual list.
Medscape Medical News, December 28, 2023
Alert FDA Expands Label for CVRx Barostim System in HF The Barostim neuromodulation system is now indicated in NYHA class III or class II HF despite guideline-directed medical therapies, with LVEF ≤ 35% and NT-proBNP < 1600 pg/mL.
Medscape Medical News, December 27, 2023
Can a Healthy Gut Microbiome Prevent Kidney Stones? Patients with kidney stones show key alterations in gut and urinary microbiota compared with those without.
Medscape Medical News, December 22, 2023
Your Patient Has a Drug Addiction, What's After Screening? Primary care clinicians can play a pivotal role in helping patients with substance abuse disorders achieve long-term recovery from addiction, through frequent checkup visits.
Medscape Medical News, December 22, 2023
When's Best to Re-dose Rituximab After Vasculitis Remission? A single-center study found that using B-cell levels to determine when to infuse rituximab reduced relapses in patients antineutrophil cytoplasmic antibody vasculitis.
Medscape Medical News, December 21, 2023
US FDA Approves Sweden-based Calliditas' Kidney Disease Drug The U.S. Food and Drug Administration (FDA) granted full approval to Swedish drugmaker Calliditas Therapeutics' drug to treat rare kidney disease IgA Nephropathy (IgAN), the...
Reuters Health Information, December 20, 2023
Systemic Bias in AI Models May Undermine Diagnostic Accuracy However, standard AI model predictions enhanced diagnostic accuracy by 4.4%.
Medscape Medical News, December 20, 2023
Where Is the 'Microbiome Revolution' Headed Next? Famed microbiome researcher Dr Martin J. Blaser shares what he sees as the most promising applications, and the rigorous clinical trials needed to realize them.
Medscape Medical News, December 19, 2023
Thiazide Diuretics May Promote Hyponatremia The risk for hyponatremia was higher with thiazide drugs compared with nonthiazide drugs in older adults and patients with comorbidities.
Medscape Medical News, December 18, 2023
Alert FDA Updates Labels for Two Cholesterol-Lowering Agents New bempedoic acid and bempedoic acid/ezetimibe labels add primary hyperlipidemia and remove the maximally tolerated statin requirement and statement on the effect on mortality.
Medscape Medical News, December 18, 2023
Top 10 Fictional Docs on Streaming TV Both tried-and-true and out-of-the-ordinary holiday gift ideas are offered to those seeking a great present for a physician.
Medscape News Slideshows, December 15, 2023
Fresenius Medical Care Says Data on 500,000 People Stolen in US Dialysis group Fresenius Medical Care said on Wednesday that data including medical records on 500,000 patients and former patients were stolen from a US subsidiary's data warehouse.
Reuters Health Information, December 06, 2023
New Delhi Investigating Alleged Illegal Kidney Transplants The New Delhi city government is investigating an Apollo hospital after a media report linked it to the illegal sale by Myanmar nationals of their kidneys for organ transplants.
Reuters Health Information, December 06, 2023
Reducing Albumin Improves Kidney and Heart Function The tablet drug finerenone significantly reduces kidney risk in people with type 2 diabetes and also protects heart health, researchers found.
Medscape Medical News, December 04, 2023
Statin Use Remains Low for At-Risk Patients Expanded prescribing guidelines have not boosted statin use among patients who are at risk for atherosclerotic cardiovascular disease.
Medscape Medical News, December 04, 2023
What Is the Dark Side of GLP-1 Receptor Agonists? Doctors who prescribe this class of medication should be aware of the rare side effects with which it is associated, said an obesity expert.
Medscape Medical News, December 01, 2023
Methotrexate Carries Higher Risk for Older CKD Patients Adverse event data showed an increased risk of myelosuppression, sepsis, pneumotoxic effects, or hepatotoxic effects.
Medscape Medical News, November 27, 2023
AHA 2023 Promising First Results With DNA Editing to Lower LDL The first-in-human HEART-1 trial of in vivo DNA editing called VERVE-101, shows reductions in LDL and PCSK9 protein in patients with familial hypercholesterolemia.
MDedge News, November 21, 2023
PREVENT: AHA's New Risk Calculator Incorporates CKM Health The new cardiovascular disease risk equations start at age 30, include measures of kidney and metabolic health, add heart failure, and remove race from the equations.
Medscape Medical News, November 20, 2023
Alert FDA OKs Symplicity Renal Denervation System for Hypertension After a mixed FDA panel review in August, the agency has approved Medtronic's Symplicity Spyral renal denervation system for treatment of hypertension.
Medscape Medical News, November 20, 2023
Before Signing an Offer Letter: Read This You just received an offer letter, but should you sign it right away? How legally binding is it? Is it the same as a contract? Experts weigh in.
Medscape Medical News, November 17, 2023
Kidney Week 2023 Albuminuria Reduction Fuels Finerenone's Kidney Benefits The findings of the mediation analyses underscore the important role that albuminuria plays in the nephropathy and related comorbidities associated with type 2 diabetes and CKD.
MDedge News, November 17, 2023
WHO: Smoking Cessation Reduces Risk of Type 2 Diabetes Up to 40% A policy brief details the risks of smoking in type 2 diabetes — along with the benefits of cessation; health professionals urged to help patients quit.
Medscape Medical News, November 17, 2023
AHA 2023 More Evidence of Better Outcomes With 120 mm Hg BP Target Intensive lowering of blood pressure to a systolic target < 120 mm Hg reduced cardiovascular events among high-risk individuals by 12% vs a target < 140 mm Hg in the ESPRIT trial.
Medscape Medical News, November 16, 2023
FDA Approves CorMedix's Drug for Bloodstream Infections The FDA approved CorMedix's antimicrobial drug for reduction of catheter-related bloodstream infections in patients with kidney disease, allowing the company to launch its first commercial product.
Reuters Health Information, November 15, 2023
Sleeping Beats Sitting? What a New Study Means for Your Patients Mounting evidence suggests that even small movement changes can benefit cardiometabolic health.
Medscape Medical News, November 15, 2023
'Love More': Why Doctors Should Promote Social Connection Though some may still consider it to be pseudoscience, the positive data behind social connection is hard to deny. And it's easy for physicians to push.
Medscape Medical News, November 15, 2023
T2D: Real Benefits of New Oral Antidiabetic Drugs Could combining SGLT2 inhibitors with GLP-1R agonists have a cardioprotective and nephroprotective effect for patients with type 2 diabetes?
Medscape Medical News, November 15, 2023
AHA 2023 Low-Salt Diet Cut BP by 6 mm Hg in 1 Week: CARDIA-SSBP The blood pressure reduction brought about by the low-sodium diet may be comparable to that produced by a single antihypertensive medication.
Medscape Medical News, November 15, 2023
Kidney Week 2023 CKD-EPI eGFR Formula Surpasses Alternatives in Young Adults The two alternative formulas for calculating eGFR, the CKiD U25 and the European Kidney Function Consortium equations, showed higher levels of bias that resulted in underestimates of kidney function.
MDedge News, November 15, 2023

No Results